Buy side is starting to look a little bit more healthy and the negotiations regarding Lowell Capital sound promising; hopefully something eventuates from that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025